Nothing Special   »   [go: up one dir, main page]

US3709365A - Disposable pharmaceutical sterile closures - Google Patents

Disposable pharmaceutical sterile closures Download PDF

Info

Publication number
US3709365A
US3709365A US00042354A US3709365DA US3709365A US 3709365 A US3709365 A US 3709365A US 00042354 A US00042354 A US 00042354A US 3709365D A US3709365D A US 3709365DA US 3709365 A US3709365 A US 3709365A
Authority
US
United States
Prior art keywords
housing
filter
closure
membrane
coupling means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00042354A
Inventor
T Czaplinski
T Haney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of US3709365A publication Critical patent/US3709365A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21FPROTECTION AGAINST X-RADIATION, GAMMA RADIATION, CORPUSCULAR RADIATION OR PARTICLE BOMBARDMENT; TREATING RADIOACTIVELY CONTAMINATED MATERIAL; DECONTAMINATION ARRANGEMENTS THEREFOR
    • G21F5/00Transportable or portable shielded containers
    • G21F5/015Transportable or portable shielded containers for storing radioactive sources, e.g. source carriers for irradiation units; Radioisotope containers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/26Accessories or devices or components used for biocidal treatment
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems

Definitions

  • The'stopper is of the type that can be pierced by a 58 Field 61 Search ..210/233, 446, 450, 451, 453, hypodermi nee l to aseptically remove r 210 455; 123 272 214 222 139 541 pyrogen-free material from a vial or generator.
  • the decayed product (daughter isotope) is then milked to yield the desired radioisotope.
  • the daughter radioisotope is then utilized as a tracer and depending on the isotope utilized or the composition tagged with the daughter isotope, it will localize in various areas of the body.
  • the body is then scanned with a suitable apparatus for detecting radiation, such as a scintillation spectrometer, to detect any abnormal localization of the daughter isotope.
  • a disposable, sealed, sterile closure comprising a housing having a configuration wherein one end is closed by a pierceable merribrane and the opposite end remains open, a membrane filter placed between said membrane and said open end, and a seal around said closed end of the housing to retain said membrane in position will limit the hazards of contamination over the long period of time such a system is in operation.
  • FIG. 1 is a schematic view of a generator systemhaving a sterile, sealed disposable closure therein;
  • FIG. 2 is a sectional view of the parts of a disposable sealed, sterile closure
  • eluting solution 10 is within elution bottle 12 or any other container, e.g., plastic bag.
  • the elution bottle 12 is contacted in tandem with generator system 4 by hypodermic needle 16. This allows for eluting solution 10 to flow into generator system 4.
  • Lead shielding 8 to prevent radioactive emission from the system encloses generator system 4.
  • the details of generator system 4 are more fully set out in U.S. Pat. No. 3,369,121.
  • the eluate of this system having the daughter isotope therein is removed via hypodermic needle 18 from the bottom of the generator system 4 and allowed to pass into an evacuated vial 20 through conduits 22 and 24.
  • closure 30 is more clearly seen in FIG. 2, wherein delivery conduit 22 is connected to retainer 36; retainer 36 being capable of fitting into outlet 26 of stand 28 and having grooves 38 or other coupling means to receive open end 40 of'housing 42
  • housing 42 which may be of teardrop configuration is membrane filter 45 which is cushioned on gasket 46 and supported by perforated filter support 44.
  • Pierceable membrane 48' closes housing 42 at one end and is retained in position by seal 50.
  • Seal 50 is an aluminum seal generally utilized in autoclaving pharmaceutical preparations by placing the seal around the pierceable membrane 48 and crimping said seal. This type of seal allows for stopper 48 to be satisfactorily autoclaved and maintained in sterile condition.
  • milking needle 52 is inserted into pierceable membrane 48 and eluate from elution bottle 12 passes through generator system 14. This can be accomplished by gravity flow methods or preferably by utilizing evacuated collecting vial 20 shown in FIG.
  • Housing material 42 as well as the other materials of this invention may be made of plastic or metal material which withstands autoclaving, e.g., about 1 15l25 C. for from 20-30 minutes at 15 lb./sq. in. gauge. Therefore, a plastic, such as polypropylene, can be utilized. In addition, other methods of sterilizing may be utilized, such as by gas sterilization with ethylene oxide.
  • the membrane filter 45 may be between about 0.22 and 0.45 micron when utilized for sterilizing an eluate if further assurance of sterility is desired. However, if a clear eluate solution is the only requirement, then a membrane filter having a pore size greater than about 0.50 micron can be utilized, but not toexceed 2O microns.
  • Pierceable membrane 48 can. be made of rubberlor any other pharmaceutically acceptable grade latex material which can be pierced.
  • the disposable stopper of the invention is contained within a sterile pyrogen-free wrapper.
  • a disposable closure comprising a male portion and a female portion, the female portion comprising a housing, having one end closed by a pierceable membrane and the other end open and provided with coupling means adapted to be joined to the male portion, a perforated filter support disposed in the interior of said housing, between the pierceable membrane and open end, but spaced from said open end, a filter on the support in operable relation with said membrane, said filter and support being retained in a recess in said housing, and a seal around said closed end of the housing to retain said membrane in position; and the male portion comprising a housing, said male housing comprising coupling means on opposite ends of said male housing, one end of said coupling means being adapted to be joined to a delivery conduit and the otherend being constructed and arranged to be joined tov the coupling means of said female portion, said other end of said male coupling means being constructed to fit through said aperture, thereby retaining said closure on said stand.
  • the filter is a membrane filter having a pore size of from about 0.22 to about 0.45 micron.
  • the filter is a membrane filter having a pore size of from about 0.50 to 20 microns.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Disclosed herein is a disposable sealed sterile closure for use primarily in radiopharmaceutical preparations. The stopper is of the type that can be pierced by a hypodermic needle to aseptically remove sterile, pyrogen-free material from a vial or generator.

Description

UNITED STATESPATENTS Weyand et al ..2l0/446 x United States Patent 1191 1111 3,709,365 Czaplinski et al. 14 1 Jan. 9, 1973 I 54] DISPOSABLE PHARMACEUTICAL 3,392,726 7/1968 Pochyla 6161.. .;128/272 STERILE CLOSURES 2,127,203 8/1938 Brand ..l28/272 1 1 a 2,191,447 2/1940 Beardsley ..l28/272 UX [75] Inventors: Thomas V. Czaplinski, North Brunswick; Thomas A, H FOREIGN PATENTS OR APPLICATIONS East Brunswick both 692,598 8/1964 Canada ..210/233 [73] Asslgnee: t' & Sons New Primary Examiner-Reuben Friedman AssistantExaminer-Frederick F. Calvetti [22] Filed: June 1, 1970 Attorney-Lawrence S. Levinson, Merle J. Smith, v pp No: 42,354 Donald J. Perrella and Burton Rodney [57] ABSTRACT 310/233 210/446 210/451 Disclosed herein is a disposable sealed sterile closure 7 2 for use primarily in radiopharmaceutical preparations. [51] Int. Cl. ..B01d 35/00 The'stopper is of the type that can be pierced by a 58 Field 61 Search ..210/233, 446, 450, 451, 453, hypodermi nee l to aseptically remove r 210 455; 123 272 214 222 139 541 pyrogen-free material from a vial or generator.
4 Claims, 2 Drawing Figures [56] References Cited Pmrzmmm 9 191a 3.709.365
INVENTOR'SI THOMAS v. CZAPL/NSKI 2 B" THOMAS A. HANEY ATTORNEY DISPOSABLE PHARMACEUTICAL STERILE CLOSURES PRIOR ART Within the-past two decades the use of radiopharmaceuticals have gained wide acceptance by radiologists as aids in diagnosing various anatomical conditions. Various radioneuclides have become valuable diagnostic tools to the practicing physician to locate tumors and check the functioning body organs, such as the liver, kidneys, pancreatic tissue, and so forth. One of the primary sources of radioisotopes is delivered by a system commonly referred to as a radioisotope generator. In its operation a parent radioisotope is placed on a support and allowed to decay. The decayed product (daughter isotope) is then milked to yield the desired radioisotope. The daughter radioisotope is then utilized as a tracer and depending on the isotope utilized or the composition tagged with the daughter isotope, it will localize in various areas of the body. The bodyis then scanned with a suitable apparatus for detecting radiation, such as a scintillation spectrometer, to detect any abnormal localization of the daughter isotope.
Among the generators presently in use routinely or being investigated are tellurium-iodine; molybdenumtechnetium; strontium-yttrium; tin-indium, and so forth.
With the development of a sterile, pyrogen-free generator as set forth in U.S. Pat. No. 3,369,121, many of the systems previously utilized only experimentally have been accepted for routine use by the radiologists and the Atomic Energy CommissionQOne system at the present stage still in experimental use is the tin-indium generator. This generator is extremely useful since the half-life of Sn-l 13m is approximately 1 18 days, whereas the half-life of its daughter indium In-l 13111 is merely 1.73 hours. Thus the system can be set up to provide the practicing physician with available indium- 1 13m for scanning organisms for a period of from about 6 to 9 months. However, as it will be repeatedly utilized over this period of time, it is necessary to maintain sterility and nonpyrogenicity within the unit. One of the most vulnerable areas of possible contamination is the site of delivery. The discovery of a sterile, sealed disposable closure substantially reduces the likelihood of contamination to the system and allows the unit to be operational for long periods of time. Prior to this it was considered that the entire system was to be kept constantly sealed at all points.
DESCRIPTION OF INVENTION In order to reasonably assure the sterility and nonpyrogcnicity of a tin-indium ll3m generator, it has been discovered a disposable, sealed, sterile closure comprising a housing having a configuration wherein one end is closed by a pierceable merribrane and the opposite end remains open, a membrane filter placed between said membrane and said open end, and a seal around said closed end of the housing to retain said membrane in position will limit the hazards of contamination over the long period of time such a system is in operation. I i
The invention can be more fully understood by referring to the drawings, wherein:
FIG. 1 is a schematic view of a generator systemhaving a sterile, sealed disposable closure therein; and
FIG. 2 is a sectional view of the parts of a disposable sealed, sterile closure;
Referring to FIG. 1 eluting solution 10 is within elution bottle 12 or any other container, e.g., plastic bag. The elution bottle 12 is contacted in tandem with generator system 4 by hypodermic needle 16. This allows for eluting solution 10 to flow into generator system 4. Lead shielding 8 to prevent radioactive emission from the system encloses generator system 4. The details of generator system 4 are more fully set out in U.S. Pat. No. 3,369,121. The eluate of this system having the daughter isotope therein is removed via hypodermic needle 18 from the bottom of the generator system 4 and allowed to pass into an evacuated vial 20 through conduits 22 and 24. At point 26 on stand 28 which supports generator system 4 and shielding 8, there is a disposable sealed, sterile closure 30 of this invention which can be penetrated by hypodermic needle 32. It is to be understood that the generator system described herein canbe modified in various ways. For example, a continuous system where in lieu of hypodermic needles l6 and 18, the eluting solution and generator may be directly connected to stopper 30 by plastic conduits or fittings at 16 and 18.
The construction of closure 30 is more clearly seen in FIG. 2, wherein delivery conduit 22 is connected to retainer 36; retainer 36 being capable of fitting into outlet 26 of stand 28 and having grooves 38 or other coupling means to receive open end 40 of'housing 42 Within housing 42 which may be of teardrop configuration is membrane filter 45 which is cushioned on gasket 46 and supported by perforated filter support 44.
Pierceable membrane 48'closes housing 42 at one end and is retained in position by seal 50. Seal 50 is an aluminum seal generally utilized in autoclaving pharmaceutical preparations by placing the seal around the pierceable membrane 48 and crimping said seal. This type of seal allows for stopper 48 to be satisfactorily autoclaved and maintained in sterile condition. When the generator is ready for use, milking needle 52 is inserted into pierceable membrane 48 and eluate from elution bottle 12 passes through generator system 14. This can be accomplished by gravity flow methods or preferably by utilizing evacuated collecting vial 20 shown in FIG.
Housing material 42 as well as the other materials of this invention may be made of plastic or metal material which withstands autoclaving, e.g., about 1 15l25 C. for from 20-30 minutes at 15 lb./sq. in. gauge. Therefore, a plastic, such as polypropylene, can be utilized. In addition, other methods of sterilizing may be utilized, such as by gas sterilization with ethylene oxide. The membrane filter 45 may be between about 0.22 and 0.45 micron when utilized for sterilizing an eluate if further assurance of sterility is desired. However, if a clear eluate solution is the only requirement, then a membrane filter having a pore size greater than about 0.50 micron can be utilized, but not toexceed 2O microns.
Pierceable membrane 48 can. be made of rubberlor any other pharmaceutically acceptable grade latex material which can be pierced. t
In operation the disposable stopper of the invention is contained within a sterile pyrogen-free wrapper. The
3 technician desiring to utilize it merely opens the wrapper and passes it into connecting outlet 26. This procedure is generally carried on at least once a week or can berepeated as often as the technician deems to doso.
We claim:
1. In combination with a stand having an aperture, a disposable closure comprising a male portion and a female portion, the female portion comprising a housing, having one end closed by a pierceable membrane and the other end open and provided with coupling means adapted to be joined to the male portion, a perforated filter support disposed in the interior of said housing, between the pierceable membrane and open end, but spaced from said open end, a filter on the support in operable relation with said membrane, said filter and support being retained in a recess in said housing, and a seal around said closed end of the housing to retain said membrane in position; and the male portion comprising a housing, said male housing comprising coupling means on opposite ends of said male housing, one end of said coupling means being adapted to be joined to a delivery conduit and the otherend being constructed and arranged to be joined tov the coupling means of said female portion, said other end of said male coupling means being constructed to fit through said aperture, thereby retaining said closure on said stand.
2. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.22 to about 0.45 micron.
3. The closure of claim 2 having a teardrop configuration.
4. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.50 to 20 microns.

Claims (4)

1. In combination with a stand having an aperture, a disposable closure comprising a male portion and a female portion, the female portion compriSing a housing, having one end closed by a pierceable membrane and the other end open and provided with coupling means adapted to be joined to the male portion, a perforated filter support disposed in the interior of said housing, between the pierceable membrane and open end, but spaced from said open end, a filter on the support in operable relation with said membrane, said filter and support being retained in a recess in said housing, and a seal around said closed end of the housing to retain said membrane in position; and the male portion comprising a housing, said male housing comprising coupling means on opposite ends of said male housing, one end of said coupling means being adapted to be joined to a delivery conduit and the other end being constructed and arranged to be joined to the coupling means of said female portion, said other end of said male coupling means being constructed to fit through said aperture, thereby retaining said closure on said stand.
2. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.22 to about 0.45 micron.
3. The closure of claim 2 having a teardrop configuration.
4. The closure of claim 1 wherein the filter is a membrane filter having a pore size of from about 0.50 to 20 microns.
US00042354A 1970-06-01 1970-06-01 Disposable pharmaceutical sterile closures Expired - Lifetime US3709365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4235470A 1970-06-01 1970-06-01

Publications (1)

Publication Number Publication Date
US3709365A true US3709365A (en) 1973-01-09

Family

ID=21921433

Family Applications (1)

Application Number Title Priority Date Filing Date
US00042354A Expired - Lifetime US3709365A (en) 1970-06-01 1970-06-01 Disposable pharmaceutical sterile closures

Country Status (1)

Country Link
US (1) US3709365A (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819055A (en) * 1973-09-20 1974-06-25 Mu Eng & Mfg Inc Filter cup construction
US4021353A (en) * 1975-11-20 1977-05-03 Burron Medical Products, Inc. Flat profile filter
US4360435A (en) * 1979-11-01 1982-11-23 Baxter Travenol Laboratories, Inc. Process for sterilizing and transferring a solution
US4422939A (en) * 1979-11-07 1983-12-27 Texas Medical Products, Inc. Blood and perfusate filter
US4786281A (en) * 1985-08-02 1988-11-22 Farmitalia Carlo Erba S.P.A. Device for connecting one end of a liquid medicament delivery cannula to an apparatus for connecting a syringe to a vial containing the medicament
US5109160A (en) * 1990-10-12 1992-04-28 E. I. Du Pont De Nemours And Company Sterilizable radionuclide generator and method for sterilizing the same
WO1998044970A1 (en) * 1997-04-08 1998-10-15 Injectimed, Inc. Method and apparatus for collecting blood
JP2003500302A (en) * 1999-05-28 2003-01-07 ノバルティス アクチエンゲゼルシャフト Pharmaceutical package and method of sterilizing the package
US6582665B2 (en) * 2001-01-25 2003-06-24 Biomedical Polymers, Inc. Universal collection and transfer system
US20040035816A1 (en) * 2000-12-04 2004-02-26 Tadashi Okiyama Plug body for medical fluid container
US20040267228A1 (en) * 2001-09-14 2004-12-30 Hiroyuki Hattori Chemical feeding port and chemical container with the port
US20080203023A1 (en) * 2002-06-06 2008-08-28 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filtger for infusion systems
US20110186521A1 (en) * 2003-01-07 2011-08-04 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US20110215267A1 (en) * 2005-07-27 2011-09-08 Mallinckrodt, Inc. Radiation-Shielding Assemblies And Methods of Using The Same
US20120196358A1 (en) * 2009-06-01 2012-08-02 Fred Burbank Device for removing cumulus from oocytes
EP2492920A2 (en) * 2006-01-12 2012-08-29 DRAXIMAGE General Partnership Systems and methods for radioisotope generation
US10130746B2 (en) 2003-01-07 2018-11-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10189727B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10517971B2 (en) 2016-05-04 2019-12-31 Curium Us Llc Systems and methods for sterilizing sealed radionuclide generator column assemblies
US10973969B2 (en) 2005-01-07 2021-04-13 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127203A (en) * 1936-01-30 1938-08-16 Brand Albert Ampule
US2191447A (en) * 1937-04-21 1940-02-27 Emery S Beardsley Container closure
CA692598A (en) * 1964-08-18 C. Crisafi Robert Disposable filtering device for sterilization
US3386585A (en) * 1965-11-09 1968-06-04 Millipore Corp Filter holder and support
US3392726A (en) * 1965-08-09 1968-07-16 Upjohn Co Combination syringe and vial container

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA692598A (en) * 1964-08-18 C. Crisafi Robert Disposable filtering device for sterilization
US2127203A (en) * 1936-01-30 1938-08-16 Brand Albert Ampule
US2191447A (en) * 1937-04-21 1940-02-27 Emery S Beardsley Container closure
US3392726A (en) * 1965-08-09 1968-07-16 Upjohn Co Combination syringe and vial container
US3386585A (en) * 1965-11-09 1968-06-04 Millipore Corp Filter holder and support

Cited By (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819055A (en) * 1973-09-20 1974-06-25 Mu Eng & Mfg Inc Filter cup construction
US4021353A (en) * 1975-11-20 1977-05-03 Burron Medical Products, Inc. Flat profile filter
US4360435A (en) * 1979-11-01 1982-11-23 Baxter Travenol Laboratories, Inc. Process for sterilizing and transferring a solution
US4422939A (en) * 1979-11-07 1983-12-27 Texas Medical Products, Inc. Blood and perfusate filter
US4786281A (en) * 1985-08-02 1988-11-22 Farmitalia Carlo Erba S.P.A. Device for connecting one end of a liquid medicament delivery cannula to an apparatus for connecting a syringe to a vial containing the medicament
US5109160A (en) * 1990-10-12 1992-04-28 E. I. Du Pont De Nemours And Company Sterilizable radionuclide generator and method for sterilizing the same
WO1998044970A1 (en) * 1997-04-08 1998-10-15 Injectimed, Inc. Method and apparatus for collecting blood
US7051906B2 (en) * 1999-05-28 2006-05-30 Novartis Ag Package for a pharmaceutical product and method of sterilizing the package
JP2003500302A (en) * 1999-05-28 2003-01-07 ノバルティス アクチエンゲゼルシャフト Pharmaceutical package and method of sterilizing the package
US20080019863A1 (en) * 1999-05-28 2008-01-24 Kis Gyorgy L Package for a Pharmaceutical Product
US20050263478A1 (en) * 2000-12-04 2005-12-01 Jms Co., Ltd. Plug body for medical fluid container
US6918500B2 (en) * 2000-12-04 2005-07-19 Jms Co., Ltd. Plug body for medical fluid container
US7163114B2 (en) 2000-12-04 2007-01-16 Jms Co., Ltd. Plug body for medical fluid container
US20040035816A1 (en) * 2000-12-04 2004-02-26 Tadashi Okiyama Plug body for medical fluid container
US6582665B2 (en) * 2001-01-25 2003-06-24 Biomedical Polymers, Inc. Universal collection and transfer system
US20040267228A1 (en) * 2001-09-14 2004-12-30 Hiroyuki Hattori Chemical feeding port and chemical container with the port
US7322969B2 (en) * 2001-09-14 2008-01-29 Nipro Corporation Liquid-medicine injection port device, and liquid-medicine container provided with the same
US8192387B2 (en) * 2002-06-06 2012-06-05 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filter for infusion systems
US20080203023A1 (en) * 2002-06-06 2008-08-28 Nxstage Medical, Inc. Last-chance quality check and/or air/pathogen filtger for infusion systems
US8679348B2 (en) 2003-01-07 2014-03-25 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US8545428B2 (en) 2003-01-07 2013-10-01 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US11446417B2 (en) 2003-01-07 2022-09-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10420871B2 (en) 2003-01-07 2019-09-24 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10130746B2 (en) 2003-01-07 2018-11-20 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US9388059B2 (en) 2003-01-07 2016-07-12 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US20110186521A1 (en) * 2003-01-07 2011-08-04 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US11896750B2 (en) 2005-01-07 2024-02-13 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US10973969B2 (en) 2005-01-07 2021-04-13 Nxstage Medical, Inc. Filtration system for preparation of fluids for medical applications
US8633461B2 (en) 2005-07-27 2014-01-21 Mallinckrodt Llc Radiation-shielding assemblies and methods of using the same
US20110215267A1 (en) * 2005-07-27 2011-09-08 Mallinckrodt, Inc. Radiation-Shielding Assemblies And Methods of Using The Same
US8513632B2 (en) 2005-07-27 2013-08-20 Mallinckrodt Llc Radiation-shielding assemblies and methods of using the same
US20110215264A1 (en) * 2005-07-27 2011-09-08 Mallinckrodt, Inc. Radiation-Shielding Assemblies And Methods of Using The Same
US20110215266A1 (en) * 2005-07-27 2011-09-08 Mallinckrodt, Inc. Radiation-Shielding Assemblies And Methods of Using The Same
US8288744B2 (en) 2005-07-27 2012-10-16 Mallinckrodt Llc Radiation-shielding assemblies and methods of using the same
US20110215265A1 (en) * 2005-07-27 2011-09-08 Mallinckrodt, Inc. Radiation-Shielding Assemblies And Methods of Using The Same
EP2431978A1 (en) * 2005-07-27 2012-03-21 Mallinckrodt LLC Radiation-shielding assembly
US8362452B2 (en) 2005-07-27 2013-01-29 Mallinckrodt Inc. Radiation-shielding assemblies and methods of using the same
EP2492920A2 (en) * 2006-01-12 2012-08-29 DRAXIMAGE General Partnership Systems and methods for radioisotope generation
EP2492920A3 (en) * 2006-01-12 2012-12-12 DRAXIMAGE General Partnership Systems and methods for radioisotope generation
US20120196358A1 (en) * 2009-06-01 2012-08-02 Fred Burbank Device for removing cumulus from oocytes
US10189728B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10189727B2 (en) 2011-12-13 2019-01-29 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10947135B2 (en) 2011-12-13 2021-03-16 Nxstage Medical, Inc. Fluid purification methods, devices, and systems
US10517971B2 (en) 2016-05-04 2019-12-31 Curium Us Llc Systems and methods for sterilizing sealed radionuclide generator column assemblies

Similar Documents

Publication Publication Date Title
US3709365A (en) Disposable pharmaceutical sterile closures
US3774036A (en) Generation of a supply of radionuclide
JP4974250B2 (en) Radioisotope generator
US3902849A (en) Radioisotope and radiopharmaceutical generators
US3749556A (en) Radiopharmaceutical generator kit
GB2160010A (en) Elution generator and method of its manufacture
US4020351A (en) Generator system
MXPA04009980A (en) Radioisotope generator and method of construction thereof.
US7060998B2 (en) Component support and radioisotope generator including one or more component supports
EP0102121A1 (en) Shielding device for a reservoir comprising a radioactive material
JP2016500819A (en) Radioisotope concentrator
US3801818A (en) Radioactive generator with permeable closure
GB1473236A (en) Radioactive material generator
GB1582708A (en) Molybdenum-99/technetium-99m generators
US3783291A (en) Sterile generator housing and support
CA3010191A1 (en) Isotope preparation method
COLOMBETTI et al. PREPARATION AND TESTING OF A STERILE Sn113—In113m GENERATOR
Matthews et al. Radioactive ingrowth in a natural decay series. A demonstration
Sørensen et al. Microbial contamination of radionuclide generators
Hairr HEALTH PHYSICS ASPECTS OF WHOLE-BODY IRRADIATION
Gemmill Sr et al. Generator system
Gerhart Generation of a supply of radionuclide
Richards RADIOISOTOPE GENERATORS FOR CLINICAL USE.